Lung cancer study seeks best combo for tough cases

NCT ID NCT07394062

Recruiting now Knowledge-focused Sponsor: Gazi University Source: ClinicalTrials.gov ↗

First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 10 times

Summary

This study watches how two different drug combinations work in people with advanced lung cancer that has spread. It includes 400 adults whose tumors have low levels of a protein called PD-L1. The goal is to see which combo helps people live longer and feel better, without assigning any treatment—just observing real-world results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NONSMALL CELL LUNG CANCER, STAGE IV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Ankara Etlik City Hospital
RECRUITING

Ankara, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••
Gazi University Faculty of Medicine, Department of Medical Oncology
RECRUITING

Ankara, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC NONSMALL CELL LUNG CANCER METASTATIC NONSMALL CELL LUNG CANCER NONSMALL CELL LUNG CANCER, STAGE IV